TIS 0.00% 0.0¢ tissue therapies limited

Affecting lives, page-4

  1. 66 Posts.
    Professor Harding has long history in wound care being the center of his professional life.

    Your cynicism, seems a little unhealthily large, perhaps it is driven by bad previous experiences and is now disporportionate?
    At that level mother teressa was just in it for the complements, and Fred hollows just restored peoples sight so they could look him in the eye when they thanked him .
    Apart from professor harding were actual slides of wounds and then of them being healed. There was actual data about what wounds were treated and what the results were.
    So for professor harding to be hired gun, and be influencing that it would have to be...?

    Not actually seeing it. The previous results are the previous results. The current regulatory effort in the USA requires a more rigorously controlled study. More rigorously controlled is to remove what elements of luck and judgment were involved in the results of the last one.

    So the odds on the new trial being a success are TBMK based on evidence not prof hardings words, or appeal to authority (of Harding) endorsement... is for me reasonably high.
    New investors bringing in new money will of course have to make their own judgment.

    My best estimate of risk, is that people, talking the stock down, will screw current investors over by undervaluing their holdings. We will then get done out of our money, via financial shenanigans, before the product finally is then ultimately shown to work.

    But hey thats only my best understanding of the data supporting the products efficacy
    and the risks of financial shennanigans.

    You may have some other personal opinion of the validity of the actual Data,
    (but I dont remeber you expressing negative opinion on those studies or their validity in the past.)
    previously published. (note the total lack of appeal to authority in that)
    Last edited by TomBombadil: 21/10/15
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.